TABLE 2

Changes in LVEF and NYHA Functional Class in Patients with Heart Failure

Patient no.SexAge (y)LVEF (%)NYHA functional class
BSL6MBSL6M
Group A
1F80202442
2M56384041
3F87363832
4M74303632
5F75363232
6F73384631
7F84393932
8M61283241
9F80403832
10M79333232
11F78383642
12M46313231
13M87364142
14M66323032
15M65364231
 Mean73 ± 1234 ± 536 ± 63.3 ± 0.51.7 ± 0.5*
Group B
1F88364332
2M74384043
3M62323032
4F57374033
5M69322732
6F62302433
7M64344243
8M57332632
9M42362831
10F46303533
11F84282643
12M58404833
13F78383632
14M71403642
15M63243232
 Mean65 ± 1334 ± 534 ± 73.3 ± 0.52.4 ± 0.6
  • * P < 0.0001 vs. BSL and P < 0.01 vs. group B.

  • P = 0.01 vs. BSL.

  • BSL = baseline; 6M = after 6 months of therapy.